top of page

Inflammaging: How Chronic Inflammation Drives Skin Ageing

Inflammaging is a term coined in the early 2000s by Italian gerontologist Claudio Franceschi to describe a chronic low-grade inflammatory state that develops with age and contributes to many age-related conditions. In the skin, inflammaging is increasingly recognised as one of the main drivers of visible ageing — not in dramatic, acute episodes, but as a slow background process that accumulates over years.

What inflammaging actually is

Acute inflammation is a normal, protective response to injury or infection. The redness, heat, and swelling that develop around a cut or insect bite are the visible signs of an immune system doing its job. The inflammatory response resolves once the threat is neutralised, and the tissue returns to baseline.

Inflammaging is different. It refers to a persistent, low-level activation of inflammatory pathways that does not resolve. The triggers can be internal - cellular senescence, accumulated DNA damage, mitochondrial dysfunction - or external, including UV exposure, pollutants, smoking, and psychological stress.

 

The result is a tissue environment that is constantly producing low concentrations of pro-inflammatory signalling molecules, even in the absence of any obvious provocation.

Why skin is particularly vulnerable

Skin is the body’s interface with the external environment, so it sustains continuous exposure to UV radiation, pollutants, microbial pressure, mechanical stress, and temperature variation.

 

Each of these can activate inflammatory pathways. In youthful skin, the system handles this load and recovers efficiently. With age, recovery slows and the cumulative low-grade inflammatory burden grows.

The downstream consequences in skin include collagen breakdown driven by matrix metalloproteinase activity, hyperpigmentation from inflammatory melanogenesis, impaired barrier function, slower wound healing, and altered keratinocyte turnover.

 

These are the cellular and molecular processes underlying what is visually described as ageing skin.

The role of the skin microbiome

Recent research has implicated the skin microbiome in inflammaging. Specific strains of Cutibacterium acnes - a bacterium present on most adult skin - produce metabolites that activate inflammatory signalling.

 

The strain composition of someone’s skin C. acnes population appears to influence whether the bacterium contributes to inflammation or remains in a more benign protective role.

This is part of a broader pattern in which microbial community composition, rather than the simple presence or absence of any single organism, drives inflammatory outcomes.

 

The implication for skincare is that approaches which selectively address problematic strains while preserving the protective community are likely to be more effective than broad antibacterial interventions.

What the research suggests about prevention

The interventions with the strongest evidence base for slowing inflammaging are unsurprising: daily broad-spectrum UV protection, avoiding cigarette smoke, antioxidant-supportive diet and topical ingredients, managing psychological stress, and consistent gentle barrier care.

 

None of these are exciting individually, and that is part of why they are often deprioritised in favour of more dramatic-feeling interventions.

The topical ingredient categories with the most supporting evidence for inflammaging-related outcomes include retinoids, niacinamide, peptides with documented anti-inflammatory activity, antioxidants such as vitamin C and ferulic acid, and barrier-supporting lipids.

 

The effects tend to be modest individually but cumulative across years of consistent use.

Realistic expectations

Inflammaging is a slow process operating over decades. No topical intervention can reverse decades of accumulated damage, and product claims that suggest otherwise should be read sceptically.

 

What well-designed topical approaches can do is slow the rate of accumulation, support recovery from acute insults, and reduce the visible markers of low-grade inflammation. Over years rather than weeks, this matters.

Doctor In Consultation

When to Seek Additional Guidance

This page is part of a small editorial archive on skincare science. It is not medical advice. Anyone considering changes to a skincare regimen should consult a registered medical practitioner.

bottom of page